Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
New ‘capsules’ aim to deliver more effective targeted cancer drug therapies
Australian and New Zealand researchers have developed tiny metal ‘containing capsules’ for targeted delivery of…
Hospital parking fees contribute to financial toxicity for cancer patients
Transportation to and from cancer centres for outpatient cancer treatments has been identified as one…
How AI found the words to kill cancer cells
Using new machine learning techniques, researchers at UC San Francisco (UCSF) in the USA, in…
Historic commitment from Labor to cancer patients
The Royal Australian and New Zealand College of Radiologists (RANZCR) applauds Opposition Leader Bill Shorten’s announcement in the budget reply…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.